山西2025资本风云：总市值破8400亿，这只晋股狂飙187%

Core Viewpoint - The A-share market in 2025 exhibited characteristics of "fluctuating upward, structural differentiation, technology leadership, and institutional support," which are also reflected in the Shanxi sector [1]. Market Performance - As of December 31, 2025, the A-share market rose by 18.41%, exceeding 600 points, marking a 10-year high; the Shanxi sector outperformed the market with a growth of 27.41% [1]. - The total market capitalization of Shanxi A-share listed companies reached 843.93 billion yuan [3][12]. Leading Companies - Shanxi Fenjiu maintained its position as the top company in the Shanxi sector with a market capitalization of 209.468 billion yuan, followed by Daqin Railway at 103.959 billion yuan, making them the only two companies in the Shanxi region with a market cap exceeding 100 billion yuan [4][13]. - Shanxi Fenjiu reported a revenue of 32.92 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 5.0%, and a net profit attributable to shareholders of 11.41 billion yuan [5][13]. Sector Analysis - Among the 12 companies in Shanxi with a market cap over 10 billion yuan, seven belong to traditional industries such as coal and steel, while Shanxi Fenjiu is one of the few in the food sector [6][14]. - Jinbo Biological, a newcomer to the hundred billion market cap club, focuses on the research, production, and sales of medical devices and functional skincare products, and became the first company in the North Exchange to specialize in recombinant collagen [6][14][15]. Stock Price Highlights - As of the end of 2025, the highest stock prices in Shanxi were held by Jinbo Biological and Shanxi Fenjiu, with Jinbo Biological reaching a peak of 589.98 yuan per share during the year [8][16]. - Dongjie Intelligent achieved the highest annual growth rate in Shanxi with a 186.70% increase, while Kexin Development followed with a 131.53% increase [9][17].